Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis

Author： Konstan Michael W   Borowitz Drucy   Mayer-Hamblett Nicole   Milla Carlos   Hendeles Leslie   Murray Susan   Kronmal Richard A   Casey Susan   Rose Lynn M   Morgan Wayne J   Ramsey Bonnie W  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.8, 2013-08, pp. : 731-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

By Konstan Michael W   Accurso Frank J   Nasr Samya Z   Ahrens Richard C   Graff Gavin R  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 723-729

Future Science

Access to resources Recommend Favorite

Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients

By  

Respiration, Vol. 91, Iss. 4, 2016-03 ,pp. : 333-348

Karger

Access to resources Recommend Favorite

The Pathophysiology of the Pancreatic Defect in Cystic Fibrosis

By  

ACTA PAEDIATRICA, Vol. 78, Iss. S363, 1989-11 ,pp. : 41-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 5, 2015-05 ,pp. : 670-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adult cystic fibrosis patients' experiences of primary care consultations: a qualitative study

By Lowton Karen   Ballard Karen D  

British Journal of General Practice, Vol. 56, Iss. 528, 2006-07 ,pp. : 518-525

Royal College of General Practitioners

Access to resources Recommend Favorite